🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Amin Yaqubie

Memorial Sloan Kettering Cancer Center

ORCID: 0009-0001-0158-6774
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data”.

Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of clinical data

npj Precision Oncology(2023)10.1038/s41698-023-00371-2
N/A
0.453DataRank · unranked
16 citations

Kurt P. Losert, Samantha M. Maisel, Jennifer Wild, Amin Yaqubie, Michael Herman +9 more

Clinical and genomic characterization of ERBB2-altered gallbladder cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4114
N/A
0.334DataRank · unranked
4 citations

Nikolaus Schultz, Juan Carlos Roa, Henry Walch, Santiago A. Sepúlveda, James J. Harding +7 more

Clinical and Genomic Characterization of ERBB2 -Altered Gallbladder Cancer: Exploring Differences Between an American and a Chilean Cohort

JCO Global Oncology(2024)10.1200/go.24.00090
N/A
0.281DataRank · unranked
4 citations

Henry Walch, Santiago A. Sepúlveda, Nikolaus Schultz, Gonzalo Muñoz, Amin Yaqubie +11 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516
N/A
0.216DataRank · unranked
2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

Defining incidence and complications of fibrolamellar liver cancer through tiered computational analysis of multiple clinical data types.

Research Square(2022)10.21203/rs.3.rs-2082118/v1
N/A
0DataRank · unranked
0 citations

Travis Zack, Jennifer Wild, Samantha Maisel, Amin Yaqubie, Jennifer J. Knox +7 more

350P IDH2-mutated cholangiocarcinoma: A case series highlighting challenges and insights

Annals of Oncology(2025)10.1016/j.annonc.2025.05.365
N/A
0DataRank · unranked
1 citations

James J. Harding, Rohit Thummalapalli, D. Khalil, Amin Yaqubie, Eileen M. O’Reilly +2 more

Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.325
N/A
0DataRank · unranked
2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular Carcinoma

JCO Precision Oncology(2023)10.1200/po.23.00272
N/A
0DataRank · unranked
18 citations

Jessica White, Joanne F. Chou, Pin‐Jung Chen, Tae‐Hyung Kim, Danny N. Khalil +17 more

Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy

The Oncologist(2024)10.1093/oncolo/oyae110
N/A
0DataRank · unranked
5 citations

Joanne F. Chou, Henry Walch, Fergus Keane, Danny N. Khalil, Jinru Shia +20 more